Forst, T., Guthrie, R., Goldenberg, R., Yee, J., Vijapurkar, U., Meininger, G., & Stein, P. (2014). Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone. Diabetes Obes Metab.
Style de citation ChicagoForst, T., R. Guthrie, R. Goldenberg, J. Yee, U. Vijapurkar, G. Meininger, et P. Stein. "Efficacy and Safety of Canagliflozin Over 52 Weeks in Patients With Type 2 Diabetes On Background Metformin and Pioglitazone." Diabetes Obes Metab 2014.
Style de citation MLAForst, T., et al. "Efficacy and Safety of Canagliflozin Over 52 Weeks in Patients With Type 2 Diabetes On Background Metformin and Pioglitazone." Diabetes Obes Metab 2014.
Attention : ces citations peuvent ne pas être correctes à 100%.